Site Logo

Download QR

Open Free Demat Account!

Join Our 9 Lakh Customers

+91
Headphone

Home

Mutual Funds

Tata India Pharma & Healthcare Fund

Ta

Tata India Pharma & Healthcare Fund

Sectoral-PharmaRank #26
2/5

NAV (2026-07-14)

33.17

AUM

₹1,455.16 Cr

Exp. Ratio: 2.18%

RISK LEVEL

Very High

Returns & Performance

1 Year8.92%3.91% vs cat avgRank #22
3 Year21.20%1.42% vs cat avgRank #12
5 Year13.38%0.07% vs cat avgRank #6
Since Launch12.04%--

Fund vs Category Average

1Y
8.92%-3.91%
3Y
21.20%-1.42%
5Y
13.38%-0.07%

Pros & Cons

Pros

No lock-in period

Cons

1Y returns trail category average
3Y returns below category average
5Y returns below category average
Higher expense ratio (2.18%)
1Y category rank outside top 15 (#22)
Overall rank #26 in category
ISININF277K016A9
NAV₹33.17
NAV Date2026-07-14
AUM₹1,455.16 Cr
Expense Ratio2.18%
RiskVery High
Rating2 / 5
Min SIP Amount₹100
Max SIP Amount₹999999999
Min Additional Inv.₹1000
SIP AllowedYes
Plan TypeRegular
Plan OptionGrowth
Is NFONo
Fund House Incorp.1995-06-30

INVESTMENT OBJECTIVE

The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Exit Load0.25%
Stamp duty on investment0.005% (from July 1st, 2020)
Tax implicationsIf you redeem within one year, your returns will be taxed at 20%. For redemptions after one year, returns exceeding ₹1.25 lakh in a financial year will be taxed at 12.5%.

Rajat Srivastava

Mr. Srivastava has done BBA (Banking & Insurance), PGDM - IMT Ghaziabad

Prior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services

Top Holdings

Holdings data not available for this scheme